49 results
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
16 Apr 24
Connect Biopharma Reports Full Year 2023 Financial Results and Provides Business Update
4:20pm
under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.
INVESTOR CONTACT:
Tim McCarthy
LifeSci Advisors
tim@lifesciadvisors.com
6-K
CNTB
Connect Biopharma Holdings Ltd
12 Dec 23
Connect Biopharma Announces Positive Rademikibart Global Phase 2b Topline Results in Adult Patients with Moderate-to-Severe Persistent Asthma
6:10am
. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.
Exhibit Index
Exhibit
6-K
EX-99.1
CNTB
Connect Biopharma Holdings Ltd
12 Dec 23
Connect Biopharma Announces Positive Rademikibart Global Phase 2b Topline Results in Adult Patients with Moderate-to-Severe Persistent Asthma
6:10am
under the safe harbor provisions of Section 21E of the Private Securities Litigation Reform Act of 1995.
INVESTOR CONTACT:
Tim McCarthy
LifeSci
6-K
EX-99.2
CNTB
Connect Biopharma Holdings Ltd
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
in their entirety by this cautionary statement. This caution is made under the safe harbor provisions of Section 21E of the Private Securities Litigation
6-K
EX-99.1
xgt902xez fwu0ccl
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
6-K
2bldmkxfgcn nb
21 Nov 23
Exclusive License and Collaboration Agreement
6:13am
6-K
EX-99.1
javah2 atja4ba
12 Sep 23
Connect Biopharma Reports First Half 2023 Financial Results and Provides Business Update
4:47pm
6-K
2k7zbsrb
12 Sep 23
Connect Biopharma Reports First Half 2023 Financial Results and Provides Business Update
4:47pm
6-K
yzambwyzji7apowz4ea
5 Jun 23
Current report (foreign)
4:28pm
6-K
ruw7f5l wc
1 Jun 23
Current report (foreign)
4:24pm
6-K
EX-99.1
sk5p3
1 Jun 23
Current report (foreign)
4:24pm
6-K
EX-99.1
jzndc26rvcqin3rgvnx
11 Apr 23
Connect Biopharma Reports Full Year 2022 Financial Results
5:00pm
6-K
npof2cbbpdj c0ac4fe
30 Dec 22
Connect Biopharma Provides Business and Clinical Development Program Update
8:00am
6-K
EX-99.1
gca8h3gja9crc
30 Dec 22
Connect Biopharma Provides Business and Clinical Development Program Update
8:00am
6-K
xpbpibe
4 Oct 22
Current report (foreign)
7:16am
6-K
vwk3dvqiiyo1o
13 Sep 22
Connect Biopharma Reports First Half 2022 Financial Results
4:47pm
6-K
EX-99.1
otta7giyzasnq6
13 Sep 22
Connect Biopharma Reports First Half 2022 Financial Results
4:47pm
6-K
q99u8m4a ywqe
11 Jul 22
Current report (foreign)
4:30pm